Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death

Human Reproduction

Volumn 29, Issue 1, 2014, Pages 107-113

  Li, Fang ^a,b   Turan, Volkan ^a,b   Lierman, Sylvie ^c   Cuvelier, Claude ^c   De Sutter, Petra ^c   Oktay, Kutluk ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Innovation Institute for Fertility Preservation and IVF   (United States)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Apoptosis; Cyclophosphamide; Doxorubicin; Human ovarian xenograft; Sphingosine 1 phosphate

Indexed keywords

CASPASE 3; CYCLOPHOSPHAMIDE; DOXORUBICIN; SPHINGOSINE 1 PHOSPHATE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; OSMOTIC PUMP; OVARY FOLLICLE; SCID MOUSE; XENOGRAFT;

ANIMALIA; MUS; RODENTIA;

APOPTOSIS; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMAN OVARIAN XENOGRAFT; SPHINGOSINE-1-PHOSPHATE;

ADOLESCENT; ADULT; ANIMALS; APOPTOSIS; CASPASE 3; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HETEROGRAFTS; HUMANS; LYSOPHOSPHOLIPIDS; MICE; MICE, SCID; OVARIAN FOLLICLE; OVARY; SPHINGOSINE;

EID: 84890595760     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det391     Document Type: Article

References (32)

1. Ayensu-Coker L, Bauman D, Lindheim SR, Breech L. Fertility preservation in pediatric, adolescent and young adult female cancer patients. Pediatr Endocrinol Rev 2012;10:174-187.
2. Azim HA Jr, de Azambuja E, Colozza M, Bines J, Piccart MJ. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol 2011; 22:1939-1947.
3. Bonnaud S, Niaudet C, Pottier G, Gaugler MH, Millour J, Barbet J, Sabatier L, Paris F. Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res 2007;67:1803-1811.
4. Burmeister L, Kovacs GT, Osianlis T. First Australian pregnancy after ovarian tissue cryopreservation and subsequent autotransplantation. Med J Aust 2013;198:158-159.
5. Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril 2013;100:492-499 e493.
6. Cuvillier O, PirianovG, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996;381:800-803.
7. Greenspon J, Li R, Xiao L, Rao JN, Marasa BS, Strauch ED, Wang JY, Turner DJ. Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. Dig Dis Sci 2009; 54:499-510.
8. Hancke K, Strauch O, Kissel C, Gobel H, Schafer W, Denschlag D. Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil Steril 2007;87:172-177.
9. Isachenko V, Orth I, Isachenko E, Mallmann P, Peters D, Schmidt T, Morgenstern B, Foth D, Hanstein B, Rahimi G. Viability of human ovarian tissue confirmed 5 years after freezing with spontaneous ice-formation by autografting and chorio-allantoic membrane culture. Cryobiology 2013;66:233-238.
10. Jadoul P, Anckaert E, Dewandeleer A, Steffens M, DolmansMM, Vermylen C, Smitz J, Donnez J, Maiter D. Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. Fertil Steril 2011; 96:126-133 e123.
11. Jeong K, Aslan E, Ozkaya E, Sonmezer M, Oktay K. Ovarian cryopreservation. Minerva Med 2012;103:37-46.
12. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 2013;31:2500-2510.
13. Munster PN, Moore AP, Ismail-Khan R, Cox CE, Lacevic M, Gross-King M, Xu P, Carter WB, Minton SE. Randomized trial using gonadotropinreleasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol 2012;30:533-538.
14. Nakahara T, Iwase A, Nakamura T, Kondo M, Bayasula, Kobayashi H, Takikawa S, Manabe S, Goto M, Kotani T et al. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertil Steril 2012;98:1001-1008 e1001.
15. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000;342:1919.
16. Oktay K, Tilly J. Livebirth after cryopreserved ovarian tissue autotransplantation. Lancet 2004;364:2091-2092; author reply 2092-2093.
17. Oktay K, Newton H, Mullan J, Gosden RG. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod 1998;13:1133-1138.
18. Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 2001;286:1490-1493.
19. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M, Rosenwaks Z. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840.
20. Oktay K, Sonmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapyinduced gonadal injury. Oncologist 2007;12:1055-1066.
21. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 2007; 110:2222-2229.
22. Paris F, Perez GI, Fuks Z, Haimovitz-Friedman A, Nguyen H, Bose M, Ilagan A, Hunt PA, Morgan WF, Tilly JL et al. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med 2002;8:901-902.
23. Partridge AH. Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? J Clin Oncol 2012; 30:479-481.
24. Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, Przypyszny M, Winer EP. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 2008;8:65-69.
25. Peng P, Wu X, Guan T, Chen W, Zhang YL, Zhang W, Yang CH, Ye CL, Wang SL. Effect of sphingosine-1-phosphate on chemotherapy-induced ovarian damage and on the efficacy of chemotherapy in mice bearing S180 tumor. Nan Fang Yi Ke Da Xue Xue Bao 2012;32:383-386.
26. Revel A, Laufer N. Protecting female fertility from cancer therapy. Mol Cell Endocrinol 2002;187:83-91.
27. Soleimani R, Heytens E, Oktay K. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. PLoS One 2011a;6:e19475.
28. Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY) 2011b;3:782-793.
29. Tilly JL, Kolesnick RN. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim Biophys Acta 2002;1585:135-138.
30. van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. J ClinOncol 2012;30:291-299.
31. Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, GoldsteinDP, BernsteinM, Kluhsman BC, Osann K, Newlands E, Seckl MJ et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr 2005;34:94-98.
32. Yang B, ShiW, Yang J, Liu H, Zhao H, Li X, Jiao S. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a metaanalysis of randomized controlled trials. Breast 2013;22:150-157.